[
    [
        {
            "time": "",
            "original_text": "白雲山抗結核藥物吡嗪酰胺片通過一致性評價",
            "features": {
                "keywords": [
                    "白雲山",
                    "吡嗪酰胺片",
                    "一致性評價",
                    "抗結核藥物"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "醫藥"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "白雲山抗結核藥物吡嗪酰胺片通過一致性評價",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "白雲山子公司抗結核藥過評！",
            "features": {
                "keywords": [
                    "白雲山",
                    "子公司",
                    "抗結核藥",
                    "過評"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "醫藥"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "白雲山子公司抗結核藥過評！",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "白雲山：藥品吡嗪酰胺片通過仿製藥一致性評價",
            "features": {
                "keywords": [
                    "白雲山",
                    "吡嗪酰胺片",
                    "仿製藥",
                    "一致性評價"
                ],
                "sentiment_score": 0.88,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "醫藥"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "白雲山：藥品吡嗪酰胺片通過仿製藥一致性評價",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "白雲山：全資子公司吡嗪酰胺片已通過仿製藥質量和療效一致性評價",
            "features": {
                "keywords": [
                    "白雲山",
                    "全資子公司",
                    "吡嗪酰胺片",
                    "仿製藥",
                    "質量",
                    "療效",
                    "一致性評價"
                ],
                "sentiment_score": 0.92,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "醫藥"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "白雲山：全資子公司吡嗪酰胺片已通過仿製藥質量和療效一致性評價",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        }
    ]
]